| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Health In Tech, Inc. Class A Common Stock$1
+0.02 (+1.98%)
Market Cap
76.49 M
EPS
0.02
P/E Ratio
59.56 $
Value Trade
349.55 K
SEC Financials
Q1 2026Dilution Risk
Revenue
8.77 M
R&D Expenses
920.39 K
Operating CF
-3.32 M
Total Assets
28.97 M
Total Liabilities
7.36 M
Equity
21.60 M
D/E Ratio
12,345
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
10.33 M
Monthly Burn
1.11 M
Runway
8.2 mo
Burn Trend
SEC Filing
May 14, 2026
Overview
Volume
63.41 K
52 Week Range
0.55 - 4.02
% held by Insiders
69.22 %
% held by Institutions
3.95 %
Enterprise Value
68.96 M
Total Shares
45.28 M
Short %
5.75 %
Float Shares
11.82 M
Company Description
locked
Upcoming Catalyst
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in HIT
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
Biotech Analyst Ratings
Symbol
Firm
Rating
Action
Price Target
Upside
date
HIT
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HIT
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HIT
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
HIT Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
HIT Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-HIT
May 13, 2026Q1 2026 Earnings Conference Call
The Health In Tech Q1 2026 earnings conference call highlighted the company's strategic focus on expanding sales distribution and technology enhancements. CEO Tim Johnson noted the substantial potential in the self-funded insurance market, where the company's current penetration remains low. A recent $7 million PIPE investment will support initiatives to grow their distribution network and improve technological capabilities. The call also included forward-looking statements regarding the business's growth outlook and market strategies.
Read more →-HIT
May 13, 2026An AI - Powered Marketplace Platform Helping SMBs Access Better Self - Funded Health Plans Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT,"
Health In Tech, Inc. has launched an AI-powered marketplace platform aimed at helping small and medium-sized businesses (SMBs) access improved self-funded health plans. The platform seeks to address the complexities that have historically limited SMBs from leveraging these plans, thus providing greater flexibility and cost benefits. Furthermore, HIT aims to streamline health plan administration and underwriting through its integrated system, facilitating quicker onboarding for employer groups. This innovative approach could disrupt the current landscape of healthcare insurance and enhance accessibility for smaller businesses.
Read more →-HIT
May 13, 2026Health In Tech Reports First Quarter 2026 Financial Results
Health In Tech, Inc. reported a 9.4% increase in revenue for Q1 2026, totaling $8.8 million. However, the company faced a net loss of $1.6 million, contrasting with a profit in the same quarter last year. The firm reiterated its revenue guidance for 2026, projecting between $45 million and $50 million, driven by growth in distribution partners and new product features.
Read more →-HIT
Mar 27, 2026An AI-Powered Marketplace Platform Helping SMBs Access Better Self-Funded Health Plans Disclaimer & Safe Harbor This presentation has been prepared by the Health In Tech, Inc. (the "Company," "Health In Tech," "HIT," "we
Health In Tech (HIT) has introduced an AI-powered marketplace aiming to facilitate small and medium-sized businesses' (SMBs) access to self-funded health plans. The platform consolidates health plan administration and underwriting, tackling the complexities that have previously restricted SMBs from utilizing such plans. HIT operates in a significantly under-penetrated market, suggesting potential for growth, although it faces various risks including challenges with employee retention and capital access.
Read more →-HIT
Mar 27, 2026Health In Tech Announces Closing of $7.0 Million Private Placement Stuart, FL.
Health In Tech, Inc. has announced the successful closing of a $7.0 million private investment in public equity (PIPE) financing. This financing, which involved the issuance of 5,600,000 shares at $1.25 each, is aimed at bolstering the company's financial flexibility and accelerating platform development. The capital raised will support technology initiatives that enhance customer engagement. Additionally, the introduction of new long-term institutional investors is expected to strengthen the company's market presence.
Read more →-HIT
Mar 25, 2026Health In Tech Announces $7.0 Million Private Placement Stuart, FL.
Health In Tech, Inc. has announced a private placement expected to raise approximately $7 million before fees. The funds will be used for expanding sales distribution, advancing technology development, and supporting new product initiatives. The private investment in public equity (PIPE) is set to close by March 27, 2026, contingent upon customary closing conditions. The company has agreed to file a resale registration statement with the SEC to register the resale of shares issued in this placement.
Read more →-HIT
Mar 25, 2026Health In Tech Announces Fourth Quarter and Full Year 2025 Financial Results Full year 2025 Revenues of $33.3 million, up 71% YoY Full year 2025 Adjusted EBITDA of $4.1 million, up 81% YoY Stuart, FL.
Health In Tech, Inc. announced its financial results for 2025, reporting a revenue increase of 71% to $33.3 million and an Adjusted EBITDA growth of 81%. The company projects its 2026 revenues to range from $45 million to $50 million, driven by demand for its AI-enabled platform. CEO Tim Johnson highlighted production efficiencies achieved through accelerated development cycles and integration of new features. However, management cautioned that actual results may vary due to market uncertainties.
Read more →-HIT
Dec 2, 2025Health In Tech Announces Voluntary Extension of Lock-Up Period Stuart, FL.
Health In Tech has announced a voluntary extension of the lock-up period for its executive team and Board of Directors by six months. This extension means that shares held by these individuals will remain restricted from sale until June 20, 2026. The decision reflects the leadership's commitment to the company's long-term growth and confidence in its strategies. Following its IPO in December 2024, Health In Tech has been investing in system enhancements and expanding its service offerings within the self-funded healthcare ecosystem.
Read more →-HIT
Nov 12, 2025Nasdaq: HIT This Presentation has been prepared by the Company solely for informational purposes . The information included herein in this presentation has not been independently verified . No representations, warranties
Health In Tech (HIT) has prepared a presentation outlining its innovative approach to the self-funded healthcare insurance market. By leveraging AI technology, HIT allows businesses to design and implement their own healthcare plans, streamlining the complex insurance process. Additionally, HIT has signed a non-binding Letter of Intent with AlphaTON Capital to develop HITChain, a blockchain-enabled platform aimed at improving claims processing efficiency and transparency. The presentation emphasizes the potential for reducing administrative costs within the healthcare system.
Read more →-HIT
Nov 10, 2025Health In Tech Announces Third Quarter 2025 Financial Results Revenue reached $8.5 million, up 90% year over year; nine-month revenue totaled $25.8 million, representing 132% of full-year 2024 total revenue. Adjusted EBI
Health In Tech (NASDAQ: HIT) has reported a substantial financial performance for the third quarter of 2025, marking a 90% year-over-year revenue growth to $8.5 million. For the nine-month period, total revenue reached $25.8 million, which is already 132% of the full-year revenue for 2024. The company has launched new underwriting solutions aimed at streamlining the quoting process for large employers, enhancing operational efficiency. Additionally, a non-binding Letter of Intent with AlphaTON Capital will explore blockchain technology solutions for claims administration, indicating a progressive step towards modernizing healthcare processes.
Read more →-HIT
Nov 10, 2025Q3 2025 Earnings Conference Call
Health In Tech reported a strong third quarter of 2025, with revenues reaching $8.5 million, reflecting a 90% increase from the previous year. The company launched a large-employer underwriting capability, significantly enhancing its market position. Additionally, they introduced a three-year rate hold program aimed at providing cost stability for employers. Health In Tech is also collaborating with AlphaTON Capital Corp to develop a blockchain-enabled platform for claims processing, which addresses inefficiencies in the healthcare system.
Read more →-HIT
Jul 21, 2025Health In Tech Announces Second Quarter 2025 Financial Results Revenues of $9.3 million, up 86% YoY; The first-half year revenues of $17.3 million, 89% of full year 2024. Adjusted EBITDA of $1.6 million, up 134% YoY; The
Health In Tech (HIT) reported its financial results for the second quarter of 2025, highlighting substantial growth in revenue and profitability. Total revenue reached $9.3 million, an 86% increase compared to the previous year, while adjusted EBITDA also saw a significant rise of 134%. The company has expanded its distribution network significantly, adding numerous partners and indicating an increasing demand for its services. Executives expressed confidence in maintaining strong growth momentum throughout the year.
Read more →-HIT
Jun 30, 2025This Presentation has been prepared by the Company solely for informational purposes . The information included herein in this presentation has not been independently verified . No representations, warranties or undertak
Health In Tech (HIT) recently released a presentation highlighting its innovative approach to reshaping the self-funded healthcare market. The company reported $9.3 million in revenue for Q2 2025, along with a significant total addressable market worth $6.6 trillion. While the presentation underscores its technological advancements, it also emphasizes the need for caution regarding unverified data and the inherent uncertainties in forward-looking statements. The commitment to transparency and efficiency in healthcare is evident as HIT positions itself for growth in a complex industry landscape.
Read more →-HIT
Apr 10, 2025Health In Tech Announces Appointment of Sanjay Shrestha to Board of Directors Stuart, FL.
Health In Tech (HIT) has announced the appointment of Sanjay Shrestha to its Board of Directors. Shrestha brings a wealth of experience, having held key positions in the energy and technology sectors, which will contribute to the company's strategic growth initiatives. He will actively participate in several board committees, furthering Health In Tech's mission to innovate the U.S. healthcare system through technology and integration.
Read more →-HIT
Mar 31, 2025Health In Tech Announces First Quarter 2025 Financial Results Revenues increased 56% over the first quarter 2024 to $8.0 million, reflecting strong market demand Income before income taxes more than tripled to $0.7 milli
Health In Tech (Nasdaq: HIT) reported a strong financial performance for Q1 2025, with a 56% increase in revenue to $8.0 million and a tripling of income before income taxes to $0.7 million. CEO Tim Johnson highlighted the company's momentum post-IPO, driven by strategic investments in product and service innovation. Notably, the beta development of a third-party AI-powered underwriting platform has generated significant market interest. The company is on track for a full rollout by Q3 2025 and expects continued strong growth in the upcoming quarters.
Read more →-HIT
Mar 17, 2025Health In Tech Announces Fourth Quarter and Full Year 2024 Financial Results Total audited revenue for 2024 was $19.5 million. The first two months of 2025, our unaudited revenue is about $5.7million, more than 50% growt
Health In Tech (HIT) announced its financial results for 2024, reporting an audited revenue of $19.5 million. The company experienced a strategic year, completing its IPO and enhancing its technology infrastructure. In 2025, HIT plans to accelerate its growth, targeting mid-sized businesses with new underwriting solutions and expanding its product offerings. The early months of 2025 have shown strong momentum with unaudited revenues exceeding $5.7 million, reflecting more than 50% growth compared to the previous year.
Read more →-HIT
Dec 20, 2024Health In Tech, Inc. Announces Pricing of Initial Public Offering Stuart, FL
Health In Tech, Inc. has announced the pricing of its initial public offering, setting the share price at $4.00 for 2,300,000 Class A shares. The offering includes an option for underwriters to purchase an additional 345,000 shares and is set to begin trading on Nasdaq under the ticker 'HIT' on December 23, 2024. Proceeds from the IPO will be directed towards system enhancements and expansion of service offerings. The registration statement for the IPO became effective on December 19, 2024.
Read more →Competitive Position
How HIT ranks across every disease it competes inCompetitive Position is a premium feature
See how HIT ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial